Whitepaper: Prioritising innovation to get ahead of the market
Posted: 3 February 2022 | Merck | No comments yet
This whitepaper explores the conflict that exists between necessary administration tasks and innovation, demonstrating how digitalisation can help.
Administrative tasks related to inventory management are critical to a properly functioning lab, but what if they are hampering scientific innovation?
This whitepaper explores these questions and highlights the tangible benefits of a robust, automated and integrated laboratory system for inventory, safety and compliance.
LANEXO™ System Benefits:
- Improves laboratory productivity: Reduce time spent on inventory management by tracking stock levels and monitoring expiration dates.
- Supports safety & compliance: Reduce compliance & safety risks by automating traceability of reagent documentation and storage compliance check.
- Facilitates quality & data management: Reduce errors with easy specification and identity checks along experimental workflows.
Related content from this organisation
- Antibody-immunotherapy treatment shows benefit in serious endometrial cancer
- First-in-class biologic approved for rare lung disease
- Mycoplasma testing market expected to value nearly $2 million by 2031
- Pharmaceutical suspension market to witness accelerated growth
- Immunotherapy drug achieves trial-first in fifty years
Related topics
Analytical techniques, Biopharmaceuticals, Drug Delivery Systems, Formulation, QA/QC, Regulation & Legislation, Research & Development (R&D)
